Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;50(11):3302-3312.
doi: 10.1007/s00259-023-06293-2. Epub 2023 Jun 17.

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome

Affiliations

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome

Tassilo Schiebler et al. Eur J Nucl Med Mol Imaging. 2023 Sep.

Abstract

Purpose: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample.

Methods: One thousand seven hundred forty consecutive DAT-SPECT with 123I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal 123I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific 123I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC.

Results: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09-1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC).

Conclusion: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome.

Keywords: 123I-FP-CIT; Attenuation correction; Dopamine transporter; Ioflupane; SPECT; Scatter correction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Standardized display used for visual interpretation of the DAT-SPECT images
Fig. 2
Fig. 2
Histograms of the putamen SBR without ASC (left) and with ASC (right) in the sample of 1740 unselected DAT-SPECT from clinical routine. The fit by the sum of two Gaussians is indicated by a continuous line. The effect size d of the distance between the two Gaussian functions was computed according to Eq. (2)

Similar articles

Cited by

References

    1. Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, et al. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020;47:1885–912. doi: 10.1007/s00259-020-04817-8. - DOI - PMC - PubMed
    1. Berardelli A, Wenning G, Antonini A, Berg D, Bloem B, Bonifati V, et al. EFNS/MDS-ES recommendations for the diagnosis of P arkinson’s disease. Eur J Neurol. 2013;20:16–34. doi: 10.1111/ene.12022. - DOI - PubMed
    1. Wallert ED, van de Giessen E, Knol RJJ, Beudel M, de Bie RMA, Booij J. Imaging dopaminergic neurotransmission in neurodegenerative disorders. J Nucl Med. 2022;63:27S–32S. doi: 10.2967/jnumed.121.263197. - DOI - PMC - PubMed
    1. Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, et al. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging. 2016;43:1315–1322. doi: 10.1007/s00259-015-3304-2. - DOI - PubMed
    1. Zhao Y, Wu P, Wu J, Brendel M, Lu J, Ge J, et al. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning. Eur J Nucl Med Mol Imaging. 2022;49:2798–2811. doi: 10.1007/s00259-022-05804-x. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources